Monteverde Law Firm Investigates Mergers of Northrim Bancorp, Neuphoria Therapeutics, Safety Insurance, and RE/MAX

GlobeNewswire··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Class action attorney Juan Monteverde of Monteverde & Associates PC announced investigations into four proposed mergers. The firm is examining Northrim Bancorp's merger with PBCO Financial Corporation, Neuphoria Therapeutics' merger with Scancell Holdings where Neuphoria stockholders would own 11.1% of the combined company, Safety Insurance Group's sale to a Mapfre affiliate at $105.00 per share in cash, and RE/MAX Holdings' sale to The Real Brokerage where shareholders may receive 5.152 shares of the combined company or $13.80 in cash per share. The RE/MAX shareholder vote is scheduled for August 14, 2026. Monteverde & Associates PC, a national class action securities firm headquartered at the Empire State Building, has recovered millions of dollars for shareholders and was recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.

Impact on assets 8

Financials▲ · 3 stocks
Biotech & Genomic Medicine▲ · 2 stocks
Scancell Hldgs Plc
SCLP
± MixedCapitalrelevance

Scancell Holdings is merging with Neuphoria Therapeutics; the investigation is about the merger terms, but no clear positive or negative impact on Scancell is stated.

Real Estate▲ · 2 stocks
Re Max Holding
RMAX
± MixedCapitalrelevance

Merger investigation announced; outcome uncertain for RE/MAX Holdings.

Artificial Intelligence▲ · 1 stocks

Off-coverage companies 1

PBCO Financial CorporationPrivate± Mixed
Capitalrelevance

PBCO Financial Corporation is merging with Northrim Bancorp; the investigation is about the merger terms, but no clear positive or negative impact on PBCO is stated.

© 2026 MarketIVNews